3-Ethoxy-4-(1-ethylpropoxy)benzaldehyde → N-[1-[3-Ethoxy-4-(1-ethyl-propoxy)-benzyl]piperidin-4-yl]-5-methyl-nicotinamide
Reaction equation
[CH3:1][C:2]1[CH:3]=[N:4][CH:5]=[C:6]([CH:16]=1)[C:7]([NH:9][CH:10]1[CH2:15][CH2:14][NH:13][CH2:12][CH2:11]1)=[O:8].[CH2:17]([O:19][C:20]1[CH:21]=[C:22]([CH:25]=[CH:26][C:27]=1[O:28][CH:29]([CH2:32][CH3:33])[CH2:30][CH3:31])[CH:23]=O)[CH3:18]>>[CH2:17]([O:19][C:20]1[CH:21]=[C:22]([CH:25]=[CH:26][C:27]=1[O:28][CH:29]([CH2:30][CH3:31])[CH2:32][CH3:33])[CH2:23][N:13]1[CH2:12][CH2:11][CH:10]([NH:9][C:7](=[O:8])[C:6]2[CH:16]=[C:2]([CH3:1])[CH:3]=[N:4][CH:5]=2)[CH2:15][CH2:14]1)[CH3:18]Participants
3
Procedure
The title compound (14 mg, 36%) was prepared analogously to example 30 from 5-methyl-N-(piperidin-4-yl)-nicotinamide and 3-ethoxy-4-(1-ethyl-propoxy)-benzaldehyde. MS: 440.6 (MH+)
Sources & evidence
- ORD record
- ord-ddd6c363ac6440fd8d436a347ce78e3e
- Source dataset
- uspto-grants-2010_08
- Patent number
- US07772253B2
Reaction notes
Loading…